News About: Goverment


Priligy designated as drug causing misuse or abuse

The government designated Priligy (dapoxetine) as one of the drugs which are apt to lead to misuse or abuse in accordance with Article 62 of the Enforcement Regulation, Article 47 of the Pharmaceutical Affairs Law. ...

Korea’s trade deal with EU affects local health and medical industry

Trade Minister Kim Jong-hoon and his European Union (EU) ounterpart Catherine Ashton initialed the bilateral free trade pact (FTA) in Belgium on October 15. They plan to officially sign the trade pact within the f...

Government mulls switching OTC plan over 2,000 prescription drugs

The government is considering switching 1,700 insurance covered drugs into over-the-counter (OTC) products in the latter half of next year, the Ministry of Health, Welfare and Family Affairs said on October 14. In ...

Drug price cut corners local drug makers

The Korean government’s strong will to reduce snowballing medication costs has baffled domestic pharmaceutical firms as they have been largely dependent on producing and marketing generic drugs instead of inventing ne...

Two drugmakers win medication redemption lawsuit against goverment

The Seoul Central District Court ruled on October 14 that Yungin Pharm and Ildong Pharm should not refund their revenues associated with bioequivalence fabrication cases, while 60 million won was fined to six local bi...

Bill to simplify commercialization of ACT proposed

A lawmaker has proposed a bill to let an autologous cell therapy commercialize with Phase I clinical trial only, holding a promise to patients with rare or life-threatening diseases. Under the proposed bill, a drug...

HIRA criticized over Lipotor’s moderate price reduction

The Health Insurance Review and Assessment Service (HIRA)’s recent decision to make a moderate price reduction applied to Lipitor, the world's best-selling medicine made by Pfizer, has invited criticism from a lawmake...

Drug patent website satisfy users

The majority of users, who visit drug patent website “Patent Informedix”, express their satisfaction on the contents, according to a recent survey conducted by the Korea Food and Drug Administration between September ...

Government urged to delete first generic with no sales or production records

A lawmaker said that 375 generics with no sales or production performance should be deleted from a list of insurance eligible medicines in a bid to prevent doctors from prescribing such drugs. When a generic drug g...

Lee to become head of Korea Human Resource Development Institute

Lee Sang-yong, an incumbent deputy chief of the Korea Food and Drug Administration, is likely to replace Lee Sang-seok at the end of this month, according to pharmaceutical sources. Lee, who were appointed at the i...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.